Impact of Modifiable Bleeding Risk Factors on Major Bleeding in Patients With Atrial Fibrillation Anticoagulated With Rivaroxaban

BACKGROUND: Reducing major bleeding events is a challenge when managing anticoagulation in patients with atrial fibrillation. This study evaluated the impact of modifiable and nonmodifiable bleeding risk factors in patients with atrial fibrillation receiving rivaroxaban and estimated the impact of r...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Am Heart Assoc
Autori principali: Kirchhof, Paulus, Haas, Sylvia, Amarenco, Pierre, Hess, Susanne, Lambelet, Marc, van Eickels, Martin, Turpie, Alexander G. G., Camm, A. John
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2020
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7335544/
https://ncbi.nlm.nih.gov/pubmed/32079476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.118.009530
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi